Strategic Intelligence: Pharma M&A Deals 2025 - Top Themes

Strategic Intelligence: Pharma M&A Deals 2025 - Top Themes

Summary

This report analyzes the disruptive themes that have driven M&A activity in 2024 in the pharma Sector.

Key Highlights

The global pharma sector in 2024 witnessed deals worth $169 billion, a decline of 28% compared to 2023. In terms of deal volume, there was a rise of 18% to record 1,169 M&A deals in 2024. The Pharma sector recorded 48 mega deals (defined as any deal valued at more than $1 billion) in 2024, an increase of 9% compared to 2023.

Scope

• This report provides an overview of merger and acquisition activity globally in 2024 in Pharma Sector
• It identifies the themes driving most notable to deals announced in 2024 in the Pharma Sector

• Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
• In this report we have listed down the most notable deals in pharma sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.